Preventing household transmission of shiga toxin-producing Escherichia coli O157 infection: Promptly separating siblings might be the key

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages 1189-1196

  Werber, Dirk ^a,b,c   Mason, Brendan W ^a   Evans, Meirion R ^a   Salmon, Roland L ^a  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b European Programme for Intervention Epidemiology Training

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC UREMIC SYNDROME; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SECONDARY INFECTION; UNITED KINGDOM;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNICABLE DISEASE CONTROL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; PATIENT ISOLATION; RETROSPECTIVE STUDIES; SHIGA-TOXIGENIC ESCHERICHIA COLI; SIBLINGS; WALES;

EID: 42549165230     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/587670     Document Type: Article

References (31)

1. Outbreak of Verotoxin positive Escherichia coli O157 infection in South Wales autumn 2005: report from the Outbreak Control Team. 2006. Available at: http://www.wales.nhs.uk/sites3/Documents/719/ E%20coli%20O157%20OCT%20report.pdf. Accessed 15 February 2008.
2. E. coli Public Inquiry. 2008. Available at: http://www.ecoliinquirywales. org.uk/ecoliinquiry/?langpen. Accessed 15 February 2008.
3. 12 February 2008: transcript of proceedings. 2008. Available at: http: //www.ecoliinquirywales.org.uk/1941405/1941408/transcript,120208.d oc?langpen. Accessed 15 February 2008.
4. Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 1997; 349:745-6.
5. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269:883-8.
6. Al-Jader L, Salmon RL, Walker AM, Williams HM, Willshaw GA, Cheasty T. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Arch Dis Child 1999; 81:60-3.
7. Carter AO, Borczyk AA, Carlson JA, et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 1987; 317:1496-500.
8. Parry SM, Salmon RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerg Infect Dis 1998; 4:657-61.
9. Seto EY, Soller JA, Colford JM Jr. Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak. Emerg Infect Dis 2007; 13:860-6.
10. Diarrhea caused by Escherichia coli. I. Enterohemorrhagic strains. In: Heymann DL, ed. Control of communicable disease manual. 18th ed. Washington, DC: American Public Health Association, 2004:160-4.
11. Working Group of the former Public Health Laboratory Service Advisory Committee on Gastrointestinal Infections. Preventing person-to-person spread following gastrointestinal infections: guidelines for public health physicians and environmental health officers. Commun Dis Public Health 2004; 7:362-84.
12. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-86.
13. Vero-cytotoxin producing E. coli (VTEC O157) in the South Wales valleys: update. CDR Wkly 2005; 15:40.
14. Riley LW. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu Rev Microbiol 1987; 41:383-407.
15. Salmon RL, Farrell ID, Hutchison JG, et al. A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7. Epidemiol Infect 1989; 103:249-54.
16. Bruce MG, Curtis MB, Payne MM, et al. Lake-associated outbreak of Escherichia coli O157:H7 in Clark County, Washington, August 1999. Arch Pediatr Adolesc Med 2003; 157:1016-21.
17. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159:702-6.
18. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318:1728-33.
19. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310:452-4.
20. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342:1930-6.
21. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington state: the first year of statewide disease surveillance. JAMA 1989; 262:355-9.
22. Werber D, Behnke SC, Fruth A, et al. Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol 2007; 165:425-34.
23. Perry S, de la Luz SM, Hurst PK, Parsonnet J. Household transmission of gastroenteritis. Emerg Infect Dis 2005; 11:1093-6.
24. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect 1993; 110:9-16.
25. Rowe PC, Orrbine E, Ogborn M, et al. Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor. J Pediatr 1994; 124:21-6.
26. Ake JA, Jelacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115:e673-80.
27. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11:450-79.
28. Task force on the mass outbreak of diarrhea in school children of Sakai City. Report on the outbreak of E.coli O157 infection in Sakai City. Sakai, Japan: Sakai City, 1997.
29. Hibble A, Kanka D, Pencheon D, Pooles F. Guidelines in general practice: the new Tower of Babel? BMJ 1998; 317:862-3.
30. Hastings L, Stuart J, Andrews N, Begg N. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep CDR Rev 1997; 7:R195-200.
31. Purcell B, Samuelsson S, Hahne SJ, et al. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 2004; 328:1339.